| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CORBUS PHARMACEUTICALS HLDGS | 2,563,925 | 16,717,000 | 29.31% | ||
| 2 | ABEONA THERAPEUTICS INC | 1,359,767 | 8,036,000 | 14.09% | ||
| 3 | SYNTHETIC BIOLOGICS INCORPORATED | 3,734,149 | 6,609,000 | 11.59% | ||
| 4 | VASCULAR BIOGENICS LTD | 860,605 | 4,406,000 | 7.73% | ||
| 5 | CEMPRA INC | 180,800 | 4,318,000 | 7.57% | ||
| 6 | Advaxis Inc. | 275,000 | 2,857,000 | 5.01% | ||
| 7 | ALCOBRA LTD | 1,115,315 | 2,799,000 | 4.91% | ||
| 8 | VOLITIONRX LTD | 461,538 | 2,575,000 | 4.52% | ||
| 9 | AMPIO PHARMACEUTICALS INC | 2,738,322 | 2,081,000 | 3.65% | ||
| 10 | NEWLINK GENETICS CORP COM | 102,437 | 1,504,000 | 2.64% | ||
| 11 | Aldeyra Therapeutics Inc | 135,800 | 1,038,000 | 1.82% | ||
| 12 | KERYX BIOPHARMACEUTICALS INCORPORATED | 200,000 | 1,030,000 | 1.81% | ||
| 13 | RITTER PHARMACEUTICALS INC | 526,903 | 869,000 | 1.52% | ||
| 14 | Advaxis Inc. | 112,500 | 750,000 | 1.32% | ||
| 15 | OHR PHARMACEUTICAL INC | 205,000 | 568,000 | 1.00% | ||
| 16 | BIOBLAST PHARMA LTD | 250,970 | 424,000 | 0.74% | ||
| 17 | Caladrius Biosciences Inc | 55,781 | 266,000 | 0.47% | ||
| 18 | CHAMPIONS ONCOLOGY INC | 111,111 | 184,000 | 0.32% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-134459, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
